193 related articles for article (PubMed ID: 28713953)
1. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
Hu S; Ran Y; Chen W; Zhang Y; Xu Y
Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
Li H; Xiang Z; Liu Y; Xu B; Tang J
Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
[TBL] [Abstract][Full Text] [Related]
3. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
Liu Y; Geng X
Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
[TBL] [Abstract][Full Text] [Related]
5. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
6. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
Sui Y; Zhang X; Yang H; Wei W; Wang M
Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
[TBL] [Abstract][Full Text] [Related]
8. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
9. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
10. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
14. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q
Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
16. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
18. miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis.
Huang Z; Pang G; Huang YG; Li C
Exp Mol Pathol; 2020 Jun; 114():104384. PubMed ID: 31987844
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
Chen P; Zhao X; Ma L
Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
[TBL] [Abstract][Full Text] [Related]
20. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Wang B; Feng P; Xiao Z; Ren EC
J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]